Works matching IS 00070920 AND DT 2015 AND VI 113 AND IP 2


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial.

    Published in:
    British Journal of Cancer, 2015, v. 113, n. 2, p. 226, doi. 10.1038/bjc.2015.191
    By:
    • Beije, N;
    • Kraan, J;
    • Taal, W;
    • van der Holt, B;
    • Oosterkamp, H M;
    • Walenkamp, A M;
    • Beerepoot, L;
    • Hanse, M;
    • van Linde, M E;
    • Otten, A;
    • Vernhout, R M;
    • de Vos, F Y F;
    • Gratama, J W;
    • Sleijfer, S;
    • van den Bent, M J
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22